We propose to investigate the synthesis, radical trapping efficacy, diagnostic utility, neuroprotective activity, and mechanistic aspects of a series of new azulenyl nitrones that are structurally related to the novel chromotropic nitrone spin trap 5 (AZN), the first representative of this class first prepared in our laboratory in 1995. These studies will focus on the assessment of whether the designed target molecules 1-4 can be readily synthesized and exhibit improved or complementary behavior compared to other nitrone spin traps previously investigated for the aforementioned biomedical applications. All of the test compounds are azulene derivatives containing either a nitrone moiety at C-1 or vinylogous congeners thereof. The radical trapping efficacy of the test compounds will be gauged by measuring the inhibition of peroxyl radical mediated autoxidation of cumene and by direct competition with the conventional nitrone spin traps PBN and S- PBN. The development of an assay for radical driven oxidative stress in aqueous systems will be pursued with compound 4. Neuroprotective activity of the test compounds will be determined in a murine model of Parkinson's disease employing the neurotoxin MPTP. The possibility of the operation of a catalytic cycle in the biological sequestration of hydroxyl radicals by nitrones will be explored in mechanistic studies employing the stable radical cation derived from azulenyl nitrone 6. This multidisciplinary program will benefit from the input of several consultants whose principal research activities rely on the proposed techniques. Preliminary results obtained with AZN support the principal thesis of this proposal, namely that azulenyl nitrones constitute an important new class of spin trapping agents with promising diagnostic and therapeutic potential.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Medicinal Chemistry Study Section (MCHA)
Program Officer
Oliver, Eugene J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Florida International University
Schools of Arts and Sciences
United States
Zip Code
Mojumdar, Subhash C; Becker, David A; DiLabio, Gino A et al. (2004) Kinetic studies on stilbazulenyl-bis-nitrone (STAZN), a nonphenolic chain-breaking antioxidant in solution, micelles, and lipid membranes. J Org Chem 69:2929-36
Ginsberg, Myron D; Becker, David A; Busto, Raul et al. (2003) Stilbazulenyl nitrone, a novel antioxidant, is highly neuroprotective in focal ischemia. Ann Neurol 54:330-42
Becker, David A; Ley, James J; Echegoyen, Luis et al. (2002) Stilbazulenyl nitrone (STAZN): a nitronyl-substituted hydrocarbon with the potency of classical phenolic chain-breaking antioxidants. J Am Chem Soc 124:4678-84
Belayev, Ludmila; Becker, David A; Alonso, Ofelia F et al. (2002) Stilbazulenyl nitrone, a novel azulenyl nitrone antioxidant: improved neurological deficit and reduced contusion size after traumatic brain injury in rats. J Neurosurg 96:1077-83
Becker, D A (1999) Diagnostic and therapeutic applications of azulenyl nitrone spin traps. Cell Mol Life Sci 56:626-33